Search Ontology: 
        
        ChEBI
            dobutamine
- Term ID
- CHEBI:4670
- Synonyms
- 
    
        
        - (+-)-4-(2-((3-(p-hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol
- 3,4-dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine
- 4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol
- 4-{2-[3-(4-Hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol
- DL-dobutamine
- dobutamina
- dobutamine
- dobutaminum
- rac-dobutamine
- racemic-dobutamine
 
- Definition
- A catecholamine that is 4-(3-aminobutyl)phenol in which one of the hydrogens attached to the nitrogen is substituted by a 2-(3,4-dihydroxyphenyl)ethyl group. A beta1-adrenergic receptor agonist that has cardiac stimulant action without evoking vasoconstriction or tachycardia, it is used as the hydrochloride to increase the contractility of the heart in the management of acute heart failure.
- References
- 
    
        
        
    
    - CAS:34368-04-2
- DrugBank:DB00841
- Drug_Central:937
- HMDB:HMDB0014979
- KEGG:C06967
- KEGG:D03879
- LINCS:LSM-1807
- PMID:11280019
- PMID:11950781
- PMID:18323735
- PMID:22537238
- Patent:DE2317710
- Patent:US3987200
- Reaxys:2946389
- Wikipedia:Dobutamine
 
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
                
                    
                        Phenotype 
                    
                    
                
                
            
        
        
    
        
            
            
    
    
    
    
                
                    
                        Phenotype resulting from dobutamine
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype where environments contain dobutamine
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype modified by environments containing dobutamine
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype affecting dobutamine
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Human Disease Model
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    